Brief: Mauna Kea Technologies Obtains FDA Clearance For Applications Of Cellvizio Confocal Laser Endomicroscopy In Neurosurgery
May 24 (Reuters) - MAUNA KEA TECHNOLOGIES SAS MKEA.PA :
* MAUNA KEA TECHNOLOGIES OBTAINS FIRST EVER FDA CLEARANCE
FOR
APPLICATIONS OF CELLVIZIO® CONFOCAL LASER ENDOMICROSCOPY IN
NEUROSURGERY
Source text for Eikon: ID:nBwbNHTNva
Further company coverage: MKEA.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 09 20;))
Recent news on Mauna Kea Technologies SA
See all newsBrief: Mauna Kea Technologies Confirms Trajectory Toward Profitability By Year-End 2027
Brief: Mauna Kea Technologies Announces Results Of Its Combined General Meeting
French and Benelux stocks-Factors to watch 21 Nov
Brief: Mauna Kea Technologies Receives NMPA Regulatory Approval In China For Its Next-Generation Cellvizio Platform
Europe Research Roundup: Craneware, Croda, Genus